Androgen actions on central serotonin neurotransmission: Relevance for mood, mental state and memory

Behavioural Brain Research

Volumn 105, Issue 1, 1999, Pages 53-68

  Fink, George ^a   Sumner, Barbara ^a   Rosie, Roberta ^a   Wilson, Helen ^a   McQueen, Judith ^a  

^a ROYAL EDINBURGH HOSPITAL   (United Kingdom)

Author keywords

5 Hydroxytryptamine(2A) receptor; Dorsal raphe nucleus; Estrogen; Serotonin transporter; Testosterone

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; AMPHETAMINE; ANDROSTANOLONE; CHLORAMPHETAMINE; DOPAMINE; ESTRADIOL; ESTRADIOL RECEPTOR; FANANSERIN; FLUOXETINE; HALOPERIDOL; HALOTHANE; KETANSERIN; LYSERGIC ACID; SEROTONIN 2B RECEPTOR; SEROTONIN TRANSPORTER; TAMOXIFEN; TESTOSTERONE; TESTOSTERONE PROPIONATE;

BINDING SITE; BRAIN REGION; DORSAL RAPHE NUCLEUS; HUMAN; MEMORY; MENTAL HEALTH; MOOD; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; REVIEW; SEROTONINERGIC TRANSMISSION; SEX DIFFERENTIATION; SEXUAL BEHAVIOR;

EID: 0032868687     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(99)00082-0     Document Type: Article

References (93)

1. Aghajanian G.K., Marek G.J. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology. 36:1997;589-599.
2. Aghajanian G.K., Sprousse J.S., Rasmussen K. Physiology of the midbrain serotonin system. Meltzer H.Y. Psychopharmacology: the third generation of progress. 1987;141-149 Raven Press, New York.
3. Alheid G.F., de Olmos J.S., Beltramino C.A. Amygdala and extended amygdala. Paxinos G. The rat nervous system. 1995;495-578 Academic Press, San Diego.
4. Alves S.E., Weiland N.G., Hayashi S., McEwen B.S. Immunocytochemical localization of nuclear estrogen receptors and progestin receptors within the rat dorsal raphe nucleus. J. Comp. Neurol. 391:1998;322-334.
5. Ben-Ari Y. The amygdaloid complex. 1981;516 Elsevier North Holland Biomedical Press, Amsterdam.
6. Beyreuther K., Multhaup G., Masters C.L. Alzheimer's disease - genesis of amyloid. CIBA Found. Symp. 199:1996;119-131.
7. Biegon A., Reches A., Snyder L., McEwen B.S. Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones. Life Sci. 32:1983;2015-2021.
8. Birge S.J. The role of estrogen in the treatment of Alzheimer's disease. Neurology. 48(Suppl. 7):1997;S36-S41.
9. Biver F., Wikler D., Lotstra F., Damhaut P., Goldman S., Mendlewicz J. Serotonin 5-HT2A receptor imaging in major depression: focal changes in orbito-insular cortex. Br. J. Psychiatry. 171:1997;444-448.
10. 2A receptor expression. Neuroreport. 6(6):1995;901-904.
11. Chiodo L.A., Caggiula A.R. Substantia nigra dopamine neurons: alterations in basal discharge rates and autoreceptor sensitivity induced by estrogen. Neuropharmacology. 22:1983;593-599.
12. 2A receptors: emphasis on the rat frontal cortex. Neuroscience. 83:1998;829-836.
13. De Lignieres B. Transdermal dihydrotestosterone treatment of 'andropause'. Ann. Med. 25:1993;235-241.
14. 2 receptors, depression and anxiety. Pharmacol. Biochem. Behav. 29:1988;819-820.
15. Deslypere J.P., Kaufman J.M., Vermeulen T., Vogelaers D., Vandalem J.L., Vermeulen A. Influence of age on pulsatile luteinizing hormone release and responsiveness of the gonadotrophs to sex hormone feedback in men. J. Clin. Endocrinol. Metab. 64:1987;68-73.
16. Di Paolo T. Modulation of brain dopamine transmission by sex steroids. Rev. Neurosci. 5:1994;27-42.
17. 2 receptor antagonist. Br. J. Pharmacol. 105:1992;27-36.
18. Fink G. Feedback actions of target hormones on hypothalamus and pituitary with special reference to gonadal steroids. Annu. Rev. Physiol. 41:1979;571-585.
19. Fink G. The GW Harris Lecture. Steroid control of brain and pituitary function. Q. J. Exp. Physiol. 73:1988;257-293.
20. Fink G. The psychoprotective action of estrogen is mediated by central serotonergic as well as dopaminergic mechanisms. Takada A., Curzon G. Serotonin in the central nervous system and periphery. 1995;175-187 Elsevier Science BV.
21. Fink G. The psychoprotective action of oestrogen is mediated by central 5-hydroxytryptamine as well as dopamine receptors. Fuxe K., Hokfelt T., Olson L., Ottoson D., Dahlstrom A., Bjorklund A. Molecular Mechanisms of Neuronal Communication. 1996;177-204 Pergamon, Oxford.
22. Fink G., Dow R.C., McQueen J.K., Bennie J.G., Carroll S.M. Serotonergic 5-HT2A receptors important for the oestradiol-induced surge of luteinising hormone-releasing hormone in the rat. J. Neuroendocrinol. 11:1999;63-69.
23. Fink G., Henderson S.R. Steroids and pituitary responsiveness in female, androgenized female and male rats. J. Endocrinol. 73:1977;157-164.
24. Fink G., Sumner B.E.H. Oestrogen and mental state. Nature. 383:1996;306.
25. Fink G., Sumner B.E.H., McQueen J.K., Wilson H., Rosie R. Sex steroid control of mood, mental state and memory. Clin. Exp. Pharmacol. Physiol. 25:1998;764-775.
26. Frankfurt M., McKittrick C.R., Mendelson S.D., McEwen B.S. Effect of 5,7-dihydroxytryptamine, ovariectomy and gonadal steroids on serotonin receptor binding in rat brain. Neuroendocrinology. 59:1994;245-250.
27. Gregoire A.J.P., Kumar R., Everitt B., Henderson A.F., Studd J.W.W. Transdermal oestrogen for treatment of severe postnatal depression. Lancet. 347:1996;930-933.
28. Häfner H., Riecher-Rössler A., An Der Heiden W., Maurer K., Fätkenheuer B., Löffler W. Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychol. Med. 23:1993;925-940.
29. Halasy K., Miettinen R., Szabat E., Freund T.F. GABAergic interneurons are the major postsynaptic targets of median raphe afferents in the rat dentate gyrus. Eur. J. Neurosci. 4:1992;144-153.
30. Halbreich U., Endicott J., Goldstein S., Nee J. Premenstrual changes and changes in gonadal hormones. Acta Psychiatr. Scand. 74:1986;576-586.
31. Halbreich U., Rojansky N., Palter S., Tworek H., Hissin P., Wang K. Estrogen augments serotonergic activity in postmenopausal women. Biol. Psychiatry. 37:1995;434-441.
32. Harris G.W. Hormonal differentiation of the developing central nervous system with respect to patterns of endocrine function. Phil. Trans. R. Soc. Lond. 259:1970;165-177.
33. Hay A.G., Bancroft J., Johnstone E.C. Affective symptoms in women attending a menopause clinic. Br. J. Psychiatry. 164:1994;513-516.
34. Henderson S.R., Baker C., Fink G. Oestradiol-17β and pituitary responsiveness to luteinizing hormone releasing factor in the rat: a study using rectangular pulses of oestradiol-17β monitored by non-chromatographic radioimmunoassay. J. Endocrinol. 73:1977;441-453.
35. Herbison A.E. Multimodal influence of estrogen upon gonadotropin-releasing hormone neurons. Endocr. Rev. 19:1998;302-330.
36. 3H Estradiol in catecholamine neurons of rat brain stem: combined localization by autoradiography and formaldehyde-induced fluorescence. J. Comp. Neurol. 176:1977;607-630.
37. 2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dentrites. Proc. Natl. Acad. Sci. USA. 95:1998;735-740.
38. Jolas T., Aghajanian G.K. Opioids suppress spontaneous and NMDA-induced inhibitory postsynaptic currents in the dorsal raphe nucleus of the rat in vitro. Brain Res. 755:1997;229-245.
39. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA. 93:1996;5925-5930.
40. Kulkarni J., de Castella A., Smith D., Taffe J., Keks N., Copolov D. A clinical trial of the effects of estrogen in acutely psychotic women. Schizophr. Res. 20:1996;247-252.
41. 2 dopamine receptor mRNA levels in rats. Neurosci. Lett. 140:1992;5-8.
42. Lewis S. Sex and schizophrenia: Vive la différence. Br. J. Psychiatry. 161:1992;445-450.
43. Leysen J.E., Niemegeers C.J.E., Tollenaere J.P., Laduron P.M. Serotonergic component of neuroleptic receptors. Nature. 272:1978;168-171.
44. Li S., Pelletier G. Involvement of serotonin in the regulation of GnRH gene expression in the male rat brain. Neuropeptides. 29:1995;21-25.
45. MacLusky N.J., Walters M.J., Clark A.C., Toran-Allerand C.D. Aromatase in the cerebral cortex, hippocampus and midbrain: ontogeny and developmental implications. Mol. Cell. Neurosci. 5:1994;691-698.
46. 2 receptor antagonist. Pharmacological characterization of 3H-RP 62203-binding in the rat brain. Eur. J. Pharmacol. 233:1993b;37-45.
47. Malgouris C., Flamand F., Doble A. Autoradiographic studies of RP62203, a potent 5-HT2 receptor antagonist. In vitro and ex vivo selectivity profile. Eur. J. Pharmacol. 233:1993a;29-35.
48. Mamounas L.A., Mullen C.A., O'Hearn E., Molliver M.E. Dual serotonergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J. Comp. Neurol. 314:1991;558-586.
49. Mastrogiacomo I., Feghali G., Foresta C., Ruzza G. Andropause: incidence and pathogenesis. Arch. Androl. 9:1982;293-296.
50. McEwen B.S. Genomic regulation of sexual behavior. J. Steroid Biochem. 30:1988;179-183.
51. McKinlay J.B., Longcope C., Gray A. The questionable physiologic and epidemiologic basis for a male climacteric syndrome: preliminary results from the Massachusetts Male Aging Study. Maturitas. 11:1989;103-115.
52. McQueen J.K., Wilson H., Fink G. Estradiol-17β increases serotonin transporter (SERT) mRNA levels and the density of SERT binding sites in female rat brain. Mol. Brain Res. 45:1997;13-23.
53. McQueen J.K., Wilson H., Sumner B.E.H., Fink G. Serotonin transporter (SERT) mRNA and binding site densities in male rat brain affected by sex steroids. Mol. Brain Res. 63:1999;241-247.
54. Meltzer H.Y. Atypical antipsychotic drugs. Bloom F.E., Kupfer D.J. Psychopharmacology: the fourth generation of progress. 1995;1277-1286 Raven Press, New York.
55. Mitchell R., Hollist S., Rothwell C., Robertson W.R. Age related changes in the pituitary-testicular axis in normal men; lower serum testosterone results from decreased bioactive LH drive. Clin. Endocrinol. 42:1995;501-507.
56. Moss R.L., Gu Q., Wong M. Estrogen: non-transcriptional signaling pathway. Recent Prog. Horm. Res. 52:1997;33-68.
57. Mosselman S., Polman J., Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett. 392:1996;49-53.
58. Nicol-Smith L. Causality, menopause, and depression: a critical review of the literature. Br. Med. J. 313:1996;1229-1232.
59. 2C receptors stimulate amyloid precursor protein ectodomain secretion. J. Biol. Chem. 271(8):1996;4188-4194.
60. Nitsch R.M., Slack B.E., Farber S.A., Schulz J.G., Deng M., Kim C., Borghesani P.R., Korver W., Wurtman R.J., Growdon J.H. Regulation of proteolytic processing of the amyloid beta-protein precursor of Alzheimer's disease in transfected cell lines and in brain slices. J. Neural. Transm. Suppl. 44:1994;21-27.
61. Owens M.J., Nemeroff C.B. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin. Chem. 40:1994;288-295.
62. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 2nd Edition:1986;264 Academic Press, Sydney.
63. Pearlstein T., Rosen K., Stone A.B. Mood disorders and menopause. Endocrinol. Metab. Clin. North Am. 26:1997;279-294.
64. Pecins-Thompson M., Brown N.A., Bethea C.L. Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Res. Mol. Brain Res. 53:1998;120-129.
65. Pfaff D.W. Estrogens and brain function. 1980;281 Springer-Verlag.
66. Pitkänen A., Savander V., Le Doux J.E. Organization of intra-amygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdala. Trends Neurosci. 20:1997;517-523.
67. Reid R.L., Yen S.S.C. Premenstrual syndrome. Am. J. Obstet. Gynecol. 139:1981;85-104.
68. Renner K.J., Krey L.C., Luine V.N. Effect of progesterone on monoamine turnover in the brain of the estrogen-primed rat. Brain Res. Bull. 19:1987;195-202.
69. Rosie R., Wilson H., Fink G. Testosterone induces an all-or-none, exponential increase in arginine vasopressin mRNA in the bed nucleus of stria terminalis of the hypogonadal mouse. Mol. Cell. Neurosci. 4:1993;121-126.
70. 18F]altanserin and positron emission tomographic imaging. Psychiatry Res. 68:1996;11-12.
71. Sakuma Y., Pfaff W.D. Mesencephalic mechanisms for integration of female reproductive behavior in the rat. Am. J. Physiol. 237:1979;R285-R290.
72. Seeman M.V., Lang M. The role of estrogens in schizophrenia gender differences. Schizophr. Bull. 16:1990;185-195.
73. Series H.G., Cowen P.J., Sharp T. p-Chloroamphetamine (PCA), 3,4-methylenedioxymethamphetamine (MDMA) and D-fenfluramine pretreatment attenuates D-fenfluramine-evoked release of 5-HT in vivo. Psychopharmacology. 116:1994;508-514.
74. Sherwin B.B., Gelfand M.M. Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause. Am. J. Obstet. Gynecol. 151:1985;153-160.
75. Sherwood N.M., Chiappa S.A., Fink G. Immunoreactive luteinizing hormone releasing factor in pituitary stalk blood from female rats: sex steroid modulation of response to electrical stimulation of preoptic area or median eminence. J. Endocrinol. 70:1976;501-511.
76. Shughrue P.J., Lane M.V., Merchenthaler I. Comparative distribution of estrogen receptor-α and -β mRNA in the rat central nervous system. J. Comp. Neurol. 388:1997;507-525.
77. Shughrue P.J., Lane M.V., Merchenthaler I. Comparative distribution of estrogen receptor-α and -β mRNA in the rat central nervous system. J. Comp. Neurol. 388:1997;507-525.
78. 2A receptor induces an antidepressant-like effect in mice. Mol. Pharmacol. 52:1997;1056-1063.
79. Studd J., Zamblera D. Premenstrual depression. Focus Depr. 2:1994;6-9.
80. 2A receptors in forebrain is increased at pro-estrus in intact female rats. Neurosci. Lett. 234:1997;7-10.
81. Sumner B.E.H., Fink G. Effects of acute estradiol on 5-hydroxytryptamine and dopamine receptor subtype mRNA expression in female rat brain. Mol. Cell. Neurosci. 4:1993;83-92.
82. 2A receptors in cerebral cortex and nucleus accumbens in the female rat. J. Steroid Biochem. Mol. Biol. 54:1995;15-20.
83. 2A receptor mRNA and binding site densities in the male rat brain. Mol. Brain Res. 59:1998;205-214.
84. 2AR) in ovariectomized rats with or without acute estradiol replacement, 1999 [submitted].
85. Tang M., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348:1996;429-432.
86. Tansey E.M., Arbuthnott G.W., Fink G., Whale D. Oestradiol-17β increases the firing rate of antidromically identified neurones of the rat neostriatum. Neuroendocrinology. 37:1983;106-110.
87. Tenover J.S., Matsumoto A.M., Plymate S.R., Bremner W.J. The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate. J. Clin. Endocrinol. Metab. 65:1987;1118-1126.
88. Urban R.J., Veldhuis J.D., Blizzard R.M., Dufau M.L. Attenuated release of biologically active luteinizing hormone in healthy aging men. J. Clin. Invest. 81:1988;1020-1029.
89. Vermeulen A. The male climacterium. Ann. Med. 25:1993;531-534.
90. Viana M.B., Graeff F.G., Löschmann P.A. Kainate microinjection into the dorsal raphe nucleus induces 5-HT release in the amygdala and periaqueductal gray. Pharmacol. Biochem. Behav. 58:1997;167-172.
91. Wagner C.K., Morrell J.I. Distribution and steroid hormone regulation of aromatase mRNA expression in the forebrain of adult male and female rats: a cellular-level analysis using in situ hybridization. J. Comp. Neurol. 370:1996;71-84.
92. Wang C., Alexander G., Berman N., Salehian B., Davidson T., McDonald V., Steiner B., Hull L., Callegari C., Swerdloff R.S. Testosterone replacement therapy improves mood in hypogonadal men - a clinical research center study. J. Clin. Endocrinol. Metab. 81:1996;3578-3583.
93. Wright D.E., Jennes L. Lack of expression of serotonin receptor subtype-1a, -1c, and -2 mRNAs in gonadotropin-releasing hormone producing neurons of the rat'. Neurosci. Lett. 163:1993;1-4.